An In-Depth Look at Ekso Bionics Holdings Inc’s (EKSO) Stock Performance

In the past week, EKSO stock has gone down by -12.78%, with a monthly decline of -21.09% and a quarterly plunge of -53.60%. The volatility ratio for the week is 12.08%, and the volatility levels for the last 30 days are 9.06% for Ekso Bionics Holdings Inc The simple moving average for the past 20 days is -14.96% for EKSO’s stock, with a -17.51% simple moving average for the past 200 days.

Is It Worth Investing in Ekso Bionics Holdings Inc (NASDAQ: EKSO) Right Now?

The 36-month beta value for EKSO is also noteworthy at 1.62. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for EKSO is 14.93M, and at present, short sellers hold a 0.90% of that float. The average trading volume of EKSO on April 24, 2024 was 168.75K shares.

EKSO) stock’s latest price update

Ekso Bionics Holdings Inc (NASDAQ: EKSO) has experienced a decline in its stock price by -9.38 compared to its previous closing price of 1.28. However, the company has seen a fall of -12.78% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-22 that SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2024 after the close of trading on Monday, April 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

EKSO Trading at -26.97% from the 50-Day Moving Average

After a stumble in the market that brought EKSO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.92% of loss for the given period.

Volatility was left at 9.06%, however, over the last 30 days, the volatility rate increased by 12.08%, as shares sank -20.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -44.76% lower at present.

During the last 5 trading sessions, EKSO fell by -12.78%, which changed the moving average for the period of 200-days by -14.07% in comparison to the 20-day moving average, which settled at $1.3495. In addition, Ekso Bionics Holdings Inc saw -53.60% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at EKSO starting from Lathan Corinna, who purchase 4,032 shares at the price of $1.24 back on Nov 02 ’23. After this action, Lathan Corinna now owns 147,990 shares of Ekso Bionics Holdings Inc, valued at $5,005 using the latest closing price.

Lathan Corinna, the Director of Ekso Bionics Holdings Inc, purchase 5,500 shares at $0.95 during a trade that took place back on Aug 23 ’23, which means that Lathan Corinna is holding 143,958 shares at $5,222 based on the most recent closing price.

Stock Fundamentals for EKSO

Current profitability levels for the company are sitting at:

  • -0.83 for the present operating margin
  • 0.5 for the gross margin

The net margin for Ekso Bionics Holdings Inc stands at -0.82. The total capital return value is set at -0.73. Equity return is now at value -79.89, with -43.53 for asset returns.

Based on Ekso Bionics Holdings Inc (EKSO), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at -1.87. The debt to equity ratio resting at 0.51. The interest coverage ratio of the stock is -47.52.

Currently, EBITDA for the company is -13.41 million with net debt to EBITDA at 0.11. When we switch over and look at the enterprise to sales, we see a ratio of 1.06. The receivables turnover for the company is 3.24for trailing twelve months and the total asset turnover is 0.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.49.

Conclusion

In summary, Ekso Bionics Holdings Inc (EKSO) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts